{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:01:40Z","timestamp":1780732900315,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"PhD Christian Brinch Mollerup"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jpba.2019.113049","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T05:32:13Z","timestamp":1576647133000},"page":"113049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Ketamine analogues: Comparative toxicokinetic in vitro\u2013in vivo extrapolation and quantification of 2-fluorodeschloroketamine in forensic blood and hair samples"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0568-0861","authenticated-orcid":false,"given":"Anders Bork","family":"Davidsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mardal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Bjerre","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Katrine","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-5134","authenticated-orcid":false,"given":"Sys Stybe","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-536X","authenticated-orcid":false,"given":"Carolina","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur","family":"Dalsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6974-5535","authenticated-orcid":false,"given":"Kristian","family":"Linnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.113049_bib0005","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.1620","article-title":"From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs","volume":"6","author":"Morris","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.113049_bib0010","article-title":"Ketamine analogues multiplying in Hong Kong","volume":"25","author":"Li","year":"2019","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.jpba.2019.113049_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Ketamine use: a review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction."},{"key":"10.1016\/j.jpba.2019.113049_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1208\/s12248-019-0338-6","article-title":"In vitro metabolism and hepatic intrinsic clearance of the synthetic cannabinoid receptor agonist JWH-122 and its four \u03c9-halogenated analogues","volume":"21","author":"Davidsen","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2019.113049_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainresbull.2016.05.002","article-title":"Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue\u2014behavioural, pharmacokinetic and metabolic studies in the Wistar rat","volume":"126","author":"Horsley","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpba.2019.113049_bib0030","series-title":"Report on the Risk Assessment of 2-(3-Methoxyphenyl)-2-(Ethylamino)Cyclohexanone (Methoxetamine) in the Framework of the Council Decision on New Psychoactive Substances","author":"EMCDDA","year":"2014"},{"key":"10.1016\/j.jpba.2019.113049_bib0035","series-title":"EMCDDA\u2013Europol 2016 Annual Report on the Implementation of Council Decision 2005\/387\/JHA, Implementation Reports, 2017","author":"EMCDDA","year":"2016"},{"key":"10.1016\/j.jpba.2019.113049_bib0040","series-title":"Annual Report on the Implementation of Council Decision 2005\/387\/JHA, Implementation Reports, 2016","author":"EMCDDA, E.M.C.D.D.A.\u2013Europol","year":"2015"},{"key":"10.1016\/j.jpba.2019.113049_bib0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00213-016-4203-3","article-title":"The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents","volume":"233","author":"Halberstadt","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpba.2019.113049_bib0050","doi-asserted-by":"crossref","first-page":"19360","DOI":"10.1039\/C8NJ03107J","article-title":"Synthesis, absolute configuration and in vitro cytotoxicity of deschloroketamine enantiomers: rediscovered and abused dissociative anaesthetic","volume":"42","author":"Jur\u00e1sek","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.jpba.2019.113049_bib0055","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1093\/jat\/bky063","article-title":"A fatal case involving N -ethyldeschloroketamine (2-Oxo-PCE) and venlafaxine","volume":"43","author":"Theofel","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2019.113049_bib0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpba.2019.113049_bib0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejmech.2012.06.043","article-title":"Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design","volume":"57","author":"Di","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2019.113049_bib0070","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1021\/jm5007935","article-title":"Rational use of plasma protein and tissue binding data in drug design","volume":"57","author":"Liu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2019.113049_bib0075","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/dta.2146","article-title":"In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples","volume":"9","author":"Noble","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.113049_bib0080","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2019.113049_bib0085","article-title":"Retrospective analysis for valproate screening targets with liquid chromatography\u2013high resolution mass spectrometry with positive electrospray ionization: an omics\u2010based approach","author":"Mollerup","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.113049_bib0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/dta.2130","article-title":"Targeted analysis of 116 drugs in hair by UHPLC-MS\/MS and its application to forensic cases","volume":"9","author":"Wang","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.113049_bib0095","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/dta.2359","article-title":"Validation of a fully automated solid-phase extraction and ultra-high-performance liquid chromatography-tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post-mortem blood and brain samples","volume":"10","author":"Nielsen","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.113049_bib0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00228-002-0439-4","article-title":"Protein binding of ketamine and its active metabolites to human serum","volume":"58","author":"Hijazi","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2019.113049_bib0105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/dta.1541","article-title":"Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine","volume":"6","author":"Menzies","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.113049_bib0110","first-page":"431","article-title":"Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine","volume":"70","author":"Ihmsen","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2019.113049_bib0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers. Studies in volunteers","volume":"57","author":"White","year":"1985","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2019.113049_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00228-015-1826-y","article-title":"Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing","volume":"71","author":"Fanta","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2019.113049_bib0125","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1460-9592.2007.02257.x","article-title":"Modeling the norketamine metabolite in children and the implications for analgesia","volume":"17","author":"Herd","year":"2007","journal-title":"Pediatr. Anesth."},{"key":"10.1016\/j.jpba.2019.113049_bib0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02791072.2013.803647","article-title":"Methoxetamine (MXE) \u2013 a phenomenological study of experiences induced by a \u201clegal high\u201d from the Internet","volume":"45","author":"Kjellgren","year":"2013","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jpba.2019.113049_bib0135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jat\/29.5.376","article-title":"Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations","volume":"29","author":"Adamowicz","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2019.113049_bib0140","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1021\/acs.molpharmaceut.8b01214","article-title":"Halogen substitution influences ketamine metabolism by cytochrome P450 2B6: in vitro and computational approaches","volume":"16","author":"Wang","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpba.2019.113049_bib0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/20961790.2017.1285219","article-title":"Metabolism and metabolomics of ketamine: a toxicological approach","volume":"2","author":"Dinis-Oliveira","year":"2017","journal-title":"Forensic Sci. Res."},{"key":"10.1016\/j.jpba.2019.113049_bib0150","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1213\/ANE.0000000000000719","article-title":"Development of rapidly metabolized and ultra-short-acting ketamine analogs","volume":"121","author":"Harvey","year":"2015","journal-title":"Anesth. Analg."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519324203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519324203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:59:52Z","timestamp":1760000392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519324203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"alternative-id":["S0731708519324203"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.113049","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine analogues: Comparative toxicokinetic in vitro\u2013in vivo extrapolation and quantification of 2-fluorodeschloroketamine in forensic blood and hair samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.113049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113049"}}